A detailed history of Pictet Asset Management Holding Sa transactions in Cure Vac N.V. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 95,362 shares of CVAC stock, worth $302,297. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95,362
Previous 95,362 -0.0%
Holding current value
$302,297
Previous $324,000 13.58%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.31 - $4.99 $192,397 - $415,612
83,289 Added 689.88%
95,362 $324,000
Q4 2023

Feb 13, 2024

BUY
$3.96 - $6.41 $47,809 - $77,387
12,073 New
12,073 $50,000

Others Institutions Holding CVAC

About CureVac N.V.


  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $594M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.